<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NNR</journal-id>
<journal-id journal-id-type="hwp">spnnr</journal-id>
<journal-id journal-id-type="nlm-ta">Neurorehabil Neural Repair</journal-id>
<journal-title>Neurorehabilitation and Neural Repair</journal-title>
<issn pub-type="ppub">1545-9683</issn>
<issn pub-type="epub">1552-6844</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1545968312437943</article-id>
<article-id pub-id-type="publisher-id">10.1177_1545968312437943</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Motl</surname><given-names>Robert W</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312437943">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sandroff</surname><given-names>Brian M</given-names></name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-1545968312437943">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Suh</surname><given-names>Yoojin</given-names></name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="aff1-1545968312437943">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sosnoff</surname><given-names>Jacob J</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1545968312437943">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1545968312437943"><label>1</label>University of Illinois at Urbana-Champaign, Urbana, IL, USA</aff>
<author-notes>
<corresp id="corresp1-1545968312437943">Robert W. Motl, Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, 350 Freer Hall, 906 South Goodwin Ave, Urbana, IL 61801, USA Email: <email>robmotl@uiuc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>26</volume>
<issue>8</issue>
<fpage>1015</fpage>
<lpage>1021</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American Society of Neurorehabilitation</copyright-holder>
</permissions>
<abstract>
<p><italic>Background</italic>. Energy cost of walking (C<sub>w</sub>) is elevated in persons with multiple sclerosis (MS), perhaps because of gait impairment, and may impact daily activity and fatigue. <italic>Objective</italic>. The authors examined for associations between C<sub>w</sub>, spatiotemporal gait parameters, daily activity, and perceived fatigue in persons with mild MS. <italic>Methods</italic>. Forty-four participants completed 4 trials of walking on a GAITRite mat and one 6-minute trial of walking on a treadmill at a constant, controlled speed of 54 m min<sup>−1</sup> while expired gases were analyzed for oxygen consumption. Participants also completed the Fatigue Severity Scale (FSS) and wore a waist-mounted accelerometer for 7 days. <italic>Results. C</italic>
<sub>w</sub> was significantly and inversely associated with gait speed (<italic>r</italic> = −.25) and stride length (<italic>r</italic> = −.32) and positively associated with double limb support (<italic>r</italic> = .27). <italic>C</italic>
<sub>w</sub> was significantly and inversely associated with daily accelerometer activity counts (<italic>r</italic> = −.35) and positively associated with FSS scores (ρ = .31). <italic>Conclusion</italic>. The results support the development and application of rehabilitation strategies to address impaired gait parameters as an approach to improve C<sub>w</sub>, daily activities, and fatigue.</p>
</abstract>
<kwd-group>
<kwd>energy expenditure</kwd>
<kwd>walking</kwd>
<kwd>multiple sclerosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1545968312437943" sec-type="intro">
<title>Introduction</title>
<p>The energy cost of walking (<italic>C</italic><sub>w</sub>), defined as the amount of oxygen consumed per kilogram of body weight per unit distance traveled (ie, mL kg<sup>−1</sup> m<sup>−1</sup>),<sup><xref ref-type="bibr" rid="bibr1-1545968312437943">1</xref></sup> is higher in persons with multiple sclerosis (MS) who have mild disability than controls.<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref></sup> Maximal oxygen consumption, by comparison, is reduced in persons with MS who have mild disability.<sup><xref ref-type="bibr" rid="bibr3-1545968312437943">3</xref></sup> This indicates that persons with MS who have mild disability would expend more energy and use a greater percentage of maximal metabolic capacity when completing everyday activities of daily living. Such effects seemingly would reduce the level of daily activity and increase the sense of fatigue and activity-related fatigability.</p>
<p>The <italic>C</italic><sub>w</sub> has been linearly associated with self-reported disability in mobility in persons with mild MS,<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref></sup> and this would suggest that parameters of impaired gait are associated with <italic>C</italic><sub>w</sub> in this population.<sup><xref ref-type="bibr" rid="bibr4-1545968312437943">4</xref></sup> There is evidence that both gait speed and stride length are reduced and double limb support is prolonged in persons with mild MS compared with controls.<sup><xref ref-type="bibr" rid="bibr5-1545968312437943">5</xref></sup> To date, researchers have not examined the association between those gait parameters and <italic>C</italic><sub>w</sub> in persons with mild MS, but there is evidence of an association between pathological gait and energy costs of walking in some neurologic and orthopedic disorders.<sup><xref ref-type="bibr" rid="bibr1-1545968312437943">1</xref></sup> Such an examination might identify targets of gait rehabilitation for reducing the <italic>C</italic><sub>w</sub> and its association with daily activity and fatigue.</p>
<p>We examined the hypotheses that (<italic>a</italic>) gait speed, stride length, and time spent in double support would be associated with <italic>C</italic><sub>w</sub> and (<italic>b</italic>) <italic>C</italic><sub>w</sub> would be associated with daily activity and perceived fatigue in persons with mild MS.</p>
</sec>
<sec id="section2-1545968312437943" sec-type="methods">
<title>Methods</title>
<sec id="section3-1545968312437943">
<title>Participants</title>
<p>The sample was recruited through direct contact with support groups of a Midwestern chapter of the National Multiple Sclerosis Society that were located within an approximately 90-minute drive of our facility. The inclusion criteria involved (<italic>a</italic>) clinically definite diagnosis of MS; (<italic>b</italic>) relapse free during the past 30 days before testing; (<italic>c</italic>) being ambulatory without an assistive device including cane, crutch, or walker; (<italic>d</italic>) being 18 to 64 years of age; (<italic>e</italic>) having the visual ability necessary to read 14-point font; (<italic>f</italic>) being willing and able to wear the accelerometer and oxygen analysis system while walking on a treadmill; and (<italic>g</italic>) absence of risk factors for undertaking exercise testing based on the Physical Activity Readiness Questionnaire (PAR-Q).<sup><xref ref-type="bibr" rid="bibr6-1545968312437943">6</xref></sup> We screened 69 persons with MS and enrolled 44 of the 69 persons who underwent screening (64%).</p>
</sec>
<sec id="section4-1545968312437943">
<title>Primary Measurements</title>
<sec id="section5-1545968312437943">
<title>Energy cost</title>
<p>Oxygen consumption (<inline-formula id="inline-formula1-1545968312437943">
<mml:math display="inline" id="math1-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub>) was measured by breath-by-breath analysis using an open-circuit spirometry system (TrueOne, Parvo Medics, Sandy, Utah) with participants breathing through a Hans Rudolph (Kansas City, Missouri) 2-way, nonrebreathable valve (Model 2700B) while walking on a motor-driven treadmill (Trackmaster model TMX425C, Full Vision, Inc, Newton, Kansas) at a constant, fixed speed. The <inline-formula id="inline-formula2-1545968312437943">
<mml:math display="inline" id="math2-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> and CO<sub>2</sub> analyzers of the spirometry system were calibrated using verified concentrations of gases, and the flow meter was calibrated using a 3-L syringe (Hans Rudolph). Resting <inline-formula id="inline-formula3-1545968312437943">
<mml:math display="inline" id="math3-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> was calculated by averaging 30-second <inline-formula id="inline-formula4-1545968312437943">
<mml:math display="inline" id="math4-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> values (mL kg<sup>−1</sup> min<sup>−1</sup>) over a 5-minute period of seated rest with higher values indicating a greater rate of resting energy expenditure. Steady-state <inline-formula id="inline-formula5-1545968312437943">
<mml:math display="inline" id="math5-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> was calculated by averaging 30-second <inline-formula id="inline-formula6-1545968312437943">
<mml:math display="inline" id="math6-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> values (mL kg<sup>−1</sup> min<sup>−1</sup>) over the final 3 minutes (minutes 4-6) of the 6-minute period of treadmill walking with higher values reflecting greater energy expenditure while walking. Importantly, the last 3 minutes of a 6-minute period of walking has yielded steady-state <inline-formula id="inline-formula7-1545968312437943">
<mml:math display="inline" id="math7-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> in persons with MS,<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref>,<xref ref-type="bibr" rid="bibr7-1545968312437943">7</xref></sup> and evidence supporting the likely ascertainment of steady-state <inline-formula id="inline-formula8-1545968312437943">
<mml:math display="inline" id="math8-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> over the last 3 minutes of the 6-minute period of treadmill walking in the present study of persons with MS is illustrated in <xref ref-type="fig" rid="fig1-1545968312437943">Figure 1</xref>. <italic>C</italic><sub>w</sub> was calculated in mL kg<sup>−1</sup> m<sup>−1</sup> by dividing the net steady-state <inline-formula id="inline-formula9-1545968312437943">
<mml:math display="inline" id="math9-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> (steady-state <inline-formula id="inline-formula10-1545968312437943">
<mml:math display="inline" id="math10-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> minus resting <inline-formula id="inline-formula11-1545968312437943">
<mml:math display="inline" id="math11-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub>) in mL kg<sup>−1</sup> min<sup>−1</sup> by a constant, controlled treadmill speed of 54 m min<sup>−1</sup>, with higher values indicating greater energy cost of walking.</p>
<fig id="fig1-1545968312437943" position="float">
<label>Figure 1.</label>
<caption>
<p>Oxygen consumption over the 6-minute period of treadmill walking in persons with mild multiple sclerosis.</p>
</caption>
<graphic xlink:href="10.1177_1545968312437943-fig1.tif"/>
</fig>
</sec>
<sec id="section6-1545968312437943">
<title>Gait parameters</title>
<p>Participants completed 4 trials of walking on a 26-foot GAITRite (CIR Systems, Inc, Havertown, Pennsylvania) electronic walkway at a comfortable pace as done in previous research involving persons with MS.<sup><xref ref-type="bibr" rid="bibr8-1545968312437943">8</xref>,<xref ref-type="bibr" rid="bibr9-1545968312437943">9</xref></sup> We recorded the velocity (m s<sup>−1</sup>), stride length (m), and double limb support (percentage of gait cycle) per walking trial based on previous research involving persons with mild MS.<sup><xref ref-type="bibr" rid="bibr5-1545968312437943">5</xref></sup> The average of the 4 trials for each variable was used in the analysis.<sup><xref ref-type="bibr" rid="bibr9-1545968312437943">9</xref></sup> Higher values for velocity and stride length indicate faster speed and longer steps while walking, respectively, whereas higher values for double support indicate a greater portion of the gait cycle with both feet on the ground during walking.</p>
</sec>
<sec id="section7-1545968312437943">
<title>Daily activity level</title>
<p>Daily activity level was measured objectively using the ActiGraph Model 7164 accelerometer.<sup><xref ref-type="bibr" rid="bibr10-1545968312437943">10</xref></sup> This accelerometer contains a single, vertical axis piezoelectric bender element that generates an electrical signal proportional to the force acting on it. The acceleration/deceleration signal is digitized by an analog-to-digital converter and numerically integrated over a preprogrammed epoch interval. At the end of each interval, the integrated value of movement counts is stored in random access memory and the integrator is reset. The monitor is programmed for start time and data collection interval, and data are retrieved for analysis via a personal computer interface and software provided with the unit. The data that are downloaded from the accelerometers are entered into Microsoft Excel for data processing. The epoch was 1 minute in this study, and the accelerometers were worn on an elastic belt around the waist on the side of the body in-line with the nondominant hip during the waking hours, except while showering, bathing, and swimming, for a 7-day period. Regarding data processing, we summed the minute-by-minute counts across each of the 7 days and then averaged the total daily movement counts across the 7 days (counts per day).<sup><xref ref-type="bibr" rid="bibr10-1545968312437943">10</xref></sup> Higher total daily movement counts reflect greater daily activity.</p>
</sec>
<sec id="section8-1545968312437943">
<title>Perceived fatigue</title>
<p>Fatigue was measured with the 9-item Fatigue Severity Scale (FSS).<sup><xref ref-type="bibr" rid="bibr11-1545968312437943">11</xref></sup> The items were rated on a 7-point scale (1 = <italic>Strongly disagree</italic> and 7 = <italic>Strongly agree</italic>) and item scores were averaged into an overall measure of a person’s severity of fatigue symptoms across the past 4 weeks that ranges between 0 and 7. Higher FSS scores reflect greater severity of fatigue.</p>
</sec>
<sec id="section9-1545968312437943">
<title>Patient Determined Disease Steps (PDDS)</title>
<p>The PDDS scale<sup><xref ref-type="bibr" rid="bibr12-1545968312437943">12</xref></sup> is a self-report measure of walking mobility using an ordinal scale of 0 (<italic>Normal</italic>) through 8 (<italic>Bedridden</italic>). The PDDS scale was developed as an inexpensive surrogate for the Expanded Disability Status Scale (EDSS),<sup><xref ref-type="bibr" rid="bibr13-1545968312437943">13</xref></sup> and scores from the PDDS are linearly and strongly related with physician-administered EDSS scores (<italic>r</italic> = .93).<sup><xref ref-type="bibr" rid="bibr12-1545968312437943">12</xref></sup></p>
</sec>
<sec id="section10-1545968312437943">
<title>Multiple Sclerosis Walking Scale–12 (MSWS-12)</title>
<p>The MSWS-12 is a 12-item patient-rated measure of the impact of MS on walking.<sup><xref ref-type="bibr" rid="bibr14-1545968312437943">14</xref></sup> The items are rated on a 5-point scale of 1 (<italic>Not at all</italic>) to 5 (<italic>Extremely</italic>), and the items represent limitations of walking during the past 2 weeks. The MSWS-12 is scored by summing the item scores, subtracting 12, dividing the difference by 48, and then multiplying the result by 100. Scores range between 0 and 100, and higher scores indicate worse walking mobility or more walking difficulty.</p>
</sec>
</sec>
<sec id="section11-1545968312437943">
<title>Protocol</title>
<p>The protocol was approved by our university institutional review board. All participants provided written informed consent. The protocol included 2 testing sessions that were separated by 7 to 14 days. On the day of the first testing session, all participants completed a demographic questionnaire and then the PDDS, MSWS-12, and FSS. The PDDS and MSWS-12 were administered for confirming the mild disability level of the sample. The participant’s height and weight (while wearing clothing) were measured using a scale-stadiometer unit (Detecto Model 3P7044, Webb City, Missouri), and participants performed 4 trials of walking at a comfortable pace on the GAITRite mat. The participants then engaged in an accommodation trial that involved wearing the oxygen analysis system while walking on a motor-driven treadmill for 5 to 10 minutes. The participants were provided with an accelerometer to wear over the next 7 days.</p>
<p>On the day of the second testing session, participants returned the accelerometer and then sat and rested in a comfortable chair in the laboratory for 10 minutes. We next connected the open-circuit spirometry system and sampled expired gases for 2 to 3 minutes as a method of confirming proper functioning of the system and stabilizing participant physiological data. This was followed by the participant sitting quietly in an armchair for 5 minutes while wearing the oxygen analysis system for generating an estimate of resting energy expenditure. The participants then undertook a 6-minute walk at a constant, controlled speed of 54 m min<sup>−1</sup> on the motor-driven treadmill while wearing the oxygen analysis system. This combination of duration and treadmill speed was consistent with previous research<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref></sup> and known to be within the comfortable tolerance for walking of all participants. The speed was verified by measuring belt length and the time for 25 revolutions of the belt. The treadmill grade (0%) was verified by a digital inclinometer (Beall Tilt Box, The Beall Tool Company, Newark, Ohio).</p>
</sec>
<sec id="section12-1545968312437943">
<title>Statistical Analysis</title>
<p>All analyses were performed using SPSS, version 18 (SPSS, Chicago, Illinois). Descriptive statistics are presented in text and tables as mean ± standard deviation (SD). Distributional statistics are presented in the tables as estimates of skewness and kurtosis. Associations among <italic>C</italic>
<sub>w</sub>, gait parameters, and daily activity were examined using Pearson product–moment correlations (<italic>r</italic>). Associations involving fatigue with the aforementioned variables were estimated using Spearman rho rank-order correlations (ρ) considering the ordered nature of data from the FSS.</p>
</sec>
</sec>
<sec id="section13-1545968312437943" sec-type="results">
<title>Results</title>
<p>The sample consisted of 44 persons with a definite diagnosis of MS (38 women and 6 men) who had a mean age, height, and weight of 47.2 ± 9.1 years, 168.2 ± 8.3 cm, and 75.7 ± 19.4 kg, respectively. There were 40 persons with relapsing–remitting MS, 2 persons with secondary progressive MS, and 2 persons with primary progressive MS. The mean duration of MS was 10.8 (SD = 7.7) years, and the median PDDS score was 1 (interquartile range = 0-3) indicating minimal disability (ie, some noticeable, but minor symptoms from MS with minimal effect on one’s lifestyle). The mean MSWS-12 score was 23.2 (SD = 20.6), further indicating minimal mobility disability in those with MS.</p>
<p>The descriptive data along with the range of scores for <italic>C</italic><sub>w</sub>, resting and steady-state <inline-formula id="inline-formula12-1545968312437943">
<mml:math display="inline" id="math12-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> values, gait parameters, daily activity, and fatigue are in <xref ref-type="table" rid="table1-1545968312437943">Table 1</xref>. The distributional data are further provided in <xref ref-type="table" rid="table1-1545968312437943">Table 1</xref> and did not identify any major problems with skewness and kurtosis for the variables. The mean values indicated that this sample of persons with mild MS had an elevated steady-state <inline-formula id="inline-formula13-1545968312437943">
<mml:math display="inline" id="math13-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula><sc>o</sc><sub>2</sub> value<sup><xref ref-type="bibr" rid="bibr15-1545968312437943">15</xref></sup> that would translate into elevated <italic>C</italic><sub>w</sub> based on the fixed, constant walking speed; reduced gait speed and stride length, but prolonged double limb support<sup><xref ref-type="bibr" rid="bibr8-1545968312437943">8</xref></sup>; low level of daily activity<sup><xref ref-type="bibr" rid="bibr10-1545968312437943">10</xref></sup>; and moderate fatigue based on a cut-off score of 4.0.<sup><xref ref-type="bibr" rid="bibr11-1545968312437943">11</xref></sup></p>
<table-wrap id="table1-1545968312437943" position="float">
<label>Table 1.</label>
<caption>
<p>Energy Cost of Walking, Gait Parameters, Daily Activity, and Perceived Fatigue in 44 Participants With Multiple Sclerosis</p>
</caption>
<graphic alternate-form-of="table1-1545968312437943" xlink:href="10.1177_1545968312437943-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="center">Mean ± SD (Range)</th>
<th align="center">Skewness</th>
<th align="center">Kurtosis</th>
</tr>
</thead>
<tbody>
<tr>
<td><italic>C</italic><sub>w</sub>, mL kg<sup>−1</sup> m<sup>−1</sup></td>
<td>0.132 ± 0.025 (0.09-0.22)</td>
<td>1.13</td>
<td>1.69</td>
</tr>
<tr>
<td>Resting <inline-formula id="inline-formula14-1545968312437943">
<mml:math display="inline" id="math14-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula>o<sub>2</sub>, mL kg<sup>−1</sup> min<sup>−1</sup></td>
<td>3.68 ± 0.57 (2.43-4.78)</td>
<td>−0.32</td>
<td>−0.26</td>
</tr>
<tr>
<td>Steady-state <inline-formula id="inline-formula15-1545968312437943">
<mml:math display="inline" id="math15-1545968312437943">
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>˙</mml:mo>
</mml:mover>
</mml:math>
</inline-formula>o<sub>2</sub>, mL kg<sup>−1</sup> min<sup>−1</sup></td>
<td>10.82 ± 1.37 (8.28-14.08)</td>
<td>0.54</td>
<td>−0.04</td>
</tr>
<tr>
<td>Gait speed, m s<sup>−1</sup></td>
<td>1.28 ± 0.21 (0.81-1.84)</td>
<td>0.21</td>
<td>0.54</td>
</tr>
<tr>
<td>Stride length, m</td>
<td>1.36 ± 0.16 (1.05-1.75)</td>
<td>0.10</td>
<td>−0.05</td>
</tr>
<tr>
<td>Double limb support, % gait cycle</td>
<td>27.4 ± 4.2 (19.8-39.6)</td>
<td>0.48</td>
<td>0.16</td>
</tr>
<tr>
<td>Daily activity, counts per day</td>
<td>223 767 ± 111 991 (87 768-500 001)</td>
<td>0.92</td>
<td>−0.02</td>
</tr>
<tr>
<td>Fatigue, 0-7</td>
<td>4.1 ± 1.8 (1.0-6.7)</td>
<td>−0.78</td>
<td>−1.08</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1545968312437943">
<p>Abbreviation: <italic>C</italic><sub>w</sub> = energy cost of walking.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The correlations among variables are provided in <xref ref-type="table" rid="table2-1545968312437943">Table 2</xref>. Regarding gait parameters, <italic>C</italic>
<sub>w</sub> was inversely associated with gait speed (<italic>r</italic> = −.25, <italic>P</italic> &lt; .05) and stride length (<italic>r</italic> = −.32, <italic>P</italic> &lt; .05) and positively associated with double limb support (<italic>r</italic> = .27, <italic>P</italic> &lt; .05). Scatter plots for the associations are provided in <xref ref-type="fig" rid="fig2-1545968312437943">Figure 2</xref>. For daily activity and fatigue, <italic>C</italic>
<sub>w</sub> was inversely associated with daily accelerometer activity counts (<italic>r</italic> = −.35, <italic>P</italic> &lt; .01) and positively associated with FSS scores (ρ = .31, <italic>P</italic> &lt; .05). Scatter plots for the associations are provided in <xref ref-type="fig" rid="fig3-1545968312437943">Figure 3</xref>.</p>
<table-wrap id="table2-1545968312437943" position="float">
<label>Table 2.</label>
<caption><p>Associations Among Energy Cost of Walking, Gait Parameters, Daily Activity, and Fatigue in the Sample of 44 Participants With Multiple Sclerosis<sup><xref ref-type="table-fn" rid="table-fn3-1545968312437943">a</xref></sup></p></caption>
<graphic alternate-form-of="table2-1545968312437943" xlink:href="10.1177_1545968312437943-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="center">1</th>
<th align="center">2</th>
<th align="center">3</th>
<th align="center">4</th>
<th align="center">5</th>
<th align="center">6</th>
</tr>
</thead>
<tbody>
<tr>
<td><italic>C</italic><sub>w</sub></td>
<td align="center">—</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Gait speed</td>
<td>−.251<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td align="center">—</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Stride length</td>
<td>−.317<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>.927<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td align="center">—</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Double support time</td>
<td>.274<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>−.761<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>−.657<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td align="center">—</td>
<td/>
<td/>
</tr>
<tr>
<td>Daily activity</td>
<td>−.348<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>.168</td>
<td>.166</td>
<td>−.213</td>
<td align="center">—</td>
<td/>
</tr>
<tr>
<td>Fatigue</td>
<td>.306<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>−.324<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>−.372<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>.420<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td>−.448<sup><xref ref-type="table-fn" rid="table-fn4-1545968312437943">b</xref></sup></td>
<td align="center">—</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1545968312437943">
<p>Abbreviation: <italic>C</italic><sub>w</sub> = energy cost of walking.</p>
</fn>
<fn id="table-fn3-1545968312437943">
<label>a</label>
<p>Correlations involving fatigue are Spearman rho rank-order coefficients, all others are Pearson product–moment correlation coefficients.</p>
</fn>
<fn id="table-fn4-1545968312437943">
<label>b</label>
<p>Denotes <italic>P</italic> value ≤.05 for the correlation coefficient.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig2-1545968312437943" position="float">
<label>Figure 2.</label>
<caption>
<p>Scatter plots along with lines of best fit and 95% confidence intervals for associations among energy cost of walking, gait speed, stride length, and double limb support in persons with mild multiple sclerosis.</p>
</caption>
<graphic xlink:href="10.1177_1545968312437943-fig2.tif"/>
</fig>
<fig id="fig3-1545968312437943" position="float">
<label>Figure 3.</label>
<caption>
<p>Scatter plots along with lines of best fit and 95% confidence intervals for associations among energy cost of walking, fatigue, and daily activity in persons with mild multiple sclerosis.</p>
</caption>
<graphic xlink:href="10.1177_1545968312437943-fig3.tif"/>
</fig>
</sec>
<sec id="section14-1545968312437943" sec-type="discussion">
<title>Discussion</title>
<p>Our results indicated that (<italic>a</italic>) gait speed, stride length, and double support were associated with <italic>C</italic><sub>w</sub> and (<italic>b</italic>) <italic>C</italic><sub>w</sub> was associated with daily activity and perceived fatigue in this sample of persons with mild MS. Collectively, these novel results indicate that persons with MS who have mild disability are likely to expend more energy when completing activities of daily living, at least partly due to impaired gait, and this increase in energy expenditure may reduce the level of daily activity and increase the perception of fatigue severity. Such results might support the development of rehabilitation interventions that target gait impairment and fitness to reduce <italic>C</italic><sub>w</sub> with possible downstream effects on daily activity and fatigue levels in persons with mild MS.</p>
<p>This study was motivated, in part, by previous reports of differences in <italic>C</italic><sub>w</sub> and gait parameters between persons with mild MS and age, sex, height, and weight matched controls.<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref>,<xref ref-type="bibr" rid="bibr5-1545968312437943">5</xref></sup> For example, one previous study compared <italic>C</italic><sub>w</sub> between persons with mild MS (n = 18) and age-, sex-, height-, and weight-matched controls (n = 18) and reported a similar difference in <italic>C</italic><sub>w</sub> while walking on a treadmill at a speed of 54 m min<sup>−1</sup>.<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref></sup> Another study reported that persons with early MS walked with altered gait speed, stride length, and double limb support compared with age- and sex-matched controls.<sup><xref ref-type="bibr" rid="bibr5-1545968312437943">5</xref></sup> Importantly, we extended the results of that previous research<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref>,<xref ref-type="bibr" rid="bibr5-1545968312437943">5</xref></sup> by demonstrating that the same gait parameters were associated with <italic>C</italic>
<sub>w</sub> in persons with mild MS. Persons with mild MS who had reduced gait speed and stride length and prolonged double limb support demonstrated an increased energetic cost of walking on a treadmill. We do note that those gait parameters are highly interrelated and might have overlapping associations with <italic>C</italic>
<sub>w</sub>. Nevertheless, this finding is consistent with previous reports that physiological energy expenditure is adversely penalized by gait abnormalities in some neurologic and orthopedic disorders,<sup><xref ref-type="bibr" rid="bibr1-1545968312437943">1</xref></sup> although such an association has not been previously demonstrated in persons with mild MS. This would support the development and application of rehabilitation strategies for mitigating the energetic penalties of gait abnormalities during ambulation, and possible approaches for this might involve a walking program with rhythmic auditory stimulation<sup><xref ref-type="bibr" rid="bibr16-1545968312437943">16</xref></sup> or functional electrical stimulation cycling.<sup><xref ref-type="bibr" rid="bibr17-1545968312437943">17</xref></sup> For example, the administration of a home-based walking program with rhythmic auditory stimulation has recently resulted in a statistically significant reduction in double limb support and trends with moderate-to-large effect sizes for increases in velocity and step length in persons with MS,<sup><xref ref-type="bibr" rid="bibr16-1545968312437943">16</xref></sup> and this might translate into improved energetic efficiency during walking.</p>
<p>The <italic>C</italic>
<sub>w</sub> among persons with mild MS was associated with both daily activity and the severity of fatigue, and we are unaware of previous research documenting such associations in this population. Indeed, those with mild MS who had an elevated <italic>C</italic>
<sub>w</sub> engaged in less daily activity as measured by free-living accelerometry and reported a greater level of perceived fatigue severity as measured by FSS. Such associations are logical as persons with MS would expend more energy when completing activities of daily living, and this seemingly would reduce the level of daily activity and increase the likelihood of severe fatigue. This further supports the importance of the development and application of rehabilitation strategies for mitigating the energetic penalties of gait abnormalities because such programs might translate into participation in more daily activity and reduced fatigue among persons with mild MS.</p>
<p>This study measured <italic>C</italic>
<sub>w</sub> during a fixed, constant walking speed of 54 m min<sup>−1</sup> on a motor-driven treadmill. The fixed, constant walking speed was considerably slower than the mean gait velocity recorded from the GAITRite for the sample of persons with MS. Importantly, the mean gait velocity from the GAITRite for the sample with MS was within the range for usual gait speed among adults.<sup><xref ref-type="bibr" rid="bibr18-1545968312437943">18</xref></sup> The fixed, constant walking speed used for measuring <italic>C</italic>
<sub>w</sub> was considerably slower than usual for those with MS and this difference could have meaningfully<sup><xref ref-type="bibr" rid="bibr19-1545968312437943">19</xref></sup> affected gait kinematics on the treadmill and, based on the speed–energy relationship,<sup><xref ref-type="bibr" rid="bibr20-1545968312437943">20</xref></sup> might have resulted in a more costly gait. By extension, perhaps there is an association between gait parameters and <italic>C</italic>
<sub>w</sub> during a fixed walking speed in persons with MS because of the reduced capacity for adapting to a different gait speed brought on by manifestations of this disabling disease.</p>
<p>This study was not focused on examining the association between gait speed and daily activity, but we note that there was not a significant association between those variables in the present study. This is inconsistent with some previous research<sup><xref ref-type="bibr" rid="bibr21-1545968312437943">21</xref></sup> that has reported an association between performance on walking tests such as the timed 25-foot walk (T25FW) or timed up-and-go (TUG) and daily steps from an ankle-worn accelerometer in persons with MS. One possible reason for the lack of an association in the present study is that we measured gait velocity during a comfortable walking speed on the GAITRite, whereas that previous research measured gait velocity during the T25FW and TUG that involve walking as quickly as possible. We further note that we relied on the metric of total activity counts per day, whereas that previous research relied on total step counts per day. Last, the sample in the present study had minimal disability, and the association between gait speed and daily activity has been stronger in those with moderate than mild MS.<sup><xref ref-type="bibr" rid="bibr21-1545968312437943">21</xref></sup> Such differences between the current and previous research might account for the discrepancy in the association between gait speed and free-living daily activity.</p>
<p>Despite the novelty and strengths of the current study, there are some limitations that should be considered in interpreting and generalizing the results. One limitation is that gait parameters are highly correlated as seen in <xref ref-type="table" rid="table2-1545968312437943">Table 2</xref> and might have overlapping associations with <italic>C</italic><sub>w</sub>. We did not examine the unique contribution of the gait variables in association with <italic>C</italic><sub>w</sub> and this should be the aim of subsequent research. The cross-sectional study design is a limitation because it does not provide longitudinal data on the possibility that an elevated <italic>C</italic><sub>w</sub> results in worsening of community ambulation and fatigue over time in persons with mild MS. This design further does not identify the direction of causality among <italic>C</italic><sub>w</sub> and gait parameters, but cross-sectional data are generally a precursor for the design of randomized controlled trials that isolate causality. We further note that the sample mostly consisted of women with relapsing–remitting MS and the results might not be representative of men and other clinical courses of MS. Last, <italic>C</italic><sub>w</sub> was measured on a treadmill rather during over-ground walking. We do note that previous research has reported a similar increase in the <italic>C</italic><sub>w</sub> during both treadmill and over-ground walking,<sup><xref ref-type="bibr" rid="bibr2-1545968312437943">2</xref></sup> and we adopted an adaptation trial for minimizing the likelihood that novelty with treadmill walking itself was attributable for an elevated <italic>C</italic>
<sub>w</sub> in persons with mild MS compared with matched controls.</p>
<p>The sense of fatigue and fatigability with activity are common complaints in persons with MS.<sup><xref ref-type="bibr" rid="bibr22-1545968312437943">22</xref><xref ref-type="bibr" rid="bibr23-1545968312437943"/>-<xref ref-type="bibr" rid="bibr24-1545968312437943">24</xref></sup> Our study demonstrated that a higher <italic>C</italic>
<sub>w</sub> was associated with gait parameters, daily activity, and fatigue in persons with mild MS. This supports the application of rehabilitation strategies to manage impaired gait parameters so that persons with mild MS can lessen the energy cost of mobility and fatigue that may interfere with the amount of their daily activities.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a grant from the Foundation of the Consortium of Multiple Sclerosis Centers.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1545968312437943">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waters</surname><given-names>S</given-names></name>
<name><surname>Mulroy</surname><given-names>S</given-names></name>
</person-group>. <article-title>The energy expenditure of normal and pathological gait</article-title>. <source>Gait Posture</source>. <year>1999</year>;<volume>9</volume>:<fpage>207</fpage>-<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr2-1545968312437943">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Motl</surname><given-names>RW</given-names></name>
<name><surname>Suh</surname><given-names>Y</given-names></name>
<name><surname>Dlugonski</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Oxygen cost of treadmill and over-ground walking in mildly disabled persons with multiple sclerosis</article-title>. <source>Neurol Sci</source>. <year>2011</year>;<volume>32</volume>:<fpage>255</fpage>-<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr3-1545968312437943">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Motl</surname><given-names>RW</given-names></name>
<name><surname>Goldman</surname><given-names>M</given-names></name>
</person-group>. <article-title>Physical inactivity, neurological disability, and cardiorespiratory fitness in multiple sclerosis</article-title>. <source>Acta Neurol Scand</source>. <year>2011</year>;<volume>123</volume>:<fpage>98</fpage>-<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr4-1545968312437943">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frohman</surname><given-names>TC</given-names></name>
<name><surname>Castro</surname><given-names>W</given-names></name>
<name><surname>Shah</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Symptomatic therapy in multiple sclerosis</article-title>. <source>Ther Adv Neurol Disord</source>. <year>2011</year>;<volume>4</volume>:<fpage>83</fpage>-<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr5-1545968312437943">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin</surname><given-names>CL</given-names></name>
<name><surname>Phillips</surname><given-names>BA</given-names></name>
<name><surname>Kilpatrick</surname><given-names>TJ</given-names></name>
<etal/>
</person-group>. <article-title>Gait and balance impairment in early multiple sclerosis in the absence of clinical disability</article-title>. <source>Mult Scler</source>. <year>2006</year>;<volume>12</volume>:<fpage>620</fpage>-<lpage>628</lpage>.</citation>
</ref>
<ref id="bibr6-1545968312437943">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>S</given-names></name>
<name><surname>Reading</surname><given-names>J</given-names></name>
<name><surname>Shephard</surname><given-names>RJ</given-names></name>
</person-group>. <article-title>Revision of the Physical Activity Readiness Questionnaire</article-title>. <source>Can J Sport Sci</source>. <year>1992</year>;<volume>17</volume>:<fpage>338</fpage>-<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr7-1545968312437943">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chetta</surname><given-names>A</given-names></name>
<name><surname>Rampello</surname><given-names>A</given-names></name>
<name><surname>Marangio</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Cardiorespiratory response to walk in multiple sclerosis patients</article-title>. <source>Respir Med</source>. <year>2004</year>;<volume>98</volume>:<fpage>522</fpage>-<lpage>529</lpage>.</citation>
</ref>
<ref id="bibr8-1545968312437943">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Givon</surname><given-names>U</given-names></name>
<name><surname>Zeilig</surname><given-names>G</given-names></name>
<name><surname>Achiron</surname><given-names>A</given-names></name>
</person-group>. <article-title>Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system</article-title>. <source>Gait Posture</source>. <year>2009</year>;<volume>29</volume>:<fpage>128</fpage>-<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr9-1545968312437943">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sosnoff</surname><given-names>JJ</given-names></name>
<name><surname>Weikert</surname><given-names>M</given-names></name>
<name><surname>Dlugonski</surname><given-names>D</given-names></name>
<name><surname>Smith</surname><given-names>DC</given-names></name>
<name><surname>Motl</surname><given-names>RW</given-names></name>
</person-group>. <article-title>Quantifying gait impairment in multiple sclerosis using GAITRite<sup>TM</sup> technology</article-title>. <source>Gait Posture</source>. <year>2011</year>;<volume>34</volume>:<fpage>145</fpage>-<lpage>147</lpage>.</citation>
</ref>
<ref id="bibr10-1545968312437943">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gosney</surname><given-names>JL</given-names></name>
<name><surname>Scott</surname><given-names>JA</given-names></name>
<name><surname>Snook</surname><given-names>EM</given-names></name>
<name><surname>Motl</surname><given-names>RW</given-names></name>
</person-group>. <article-title>Physical activity and multiple sclerosis: validity of self-report and objective measures</article-title>. <source>Fam Community Health</source>. <year>2007</year>;<volume>3</volume>:<fpage>144</fpage>-<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr11-1545968312437943">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krupp</surname><given-names>LB</given-names></name>
<name><surname>LaRocca</surname><given-names>NG</given-names></name>
<name><surname>Muir-Nash</surname><given-names>J</given-names></name>
<name><surname>Steinberg</surname><given-names>AD</given-names></name>
</person-group>. <article-title>The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus</article-title>. <source>Arch Neurol</source>. <year>1989</year>;<volume>46</volume>:<fpage>1121</fpage>-<lpage>1123</lpage>.</citation>
</ref>
<ref id="bibr12-1545968312437943">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hadjimichael</surname><given-names>O</given-names></name>
<name><surname>Kerns</surname><given-names>RB</given-names></name>
<name><surname>Rizzo</surname><given-names>MA</given-names></name>
<name><surname>Cutter</surname><given-names>G</given-names></name>
<name><surname>Vollmer</surname><given-names>T</given-names></name>
</person-group>. <article-title>Persistent pain and uncomfortable sensations in persons with multiple sclerosis</article-title>. <source>Pain</source>. <year>2007</year>;<volume>127</volume>:<fpage>35</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr13-1545968312437943">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurtzke</surname><given-names>JF</given-names></name>
</person-group>. <article-title>Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)</article-title>. <source>Neurology</source>. <year>1983</year>;<volume>33</volume>:<fpage>1444</fpage>-<lpage>1452</lpage>.</citation>
</ref>
<ref id="bibr14-1545968312437943">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hobart</surname><given-names>JC</given-names></name>
<name><surname>Riazi</surname><given-names>A</given-names></name>
<name><surname>Lamping</surname><given-names>DL</given-names></name>
<name><surname>Fitzpatrick</surname><given-names>R</given-names></name>
<name><surname>Thompson</surname><given-names>AJ</given-names></name>
</person-group>. <article-title>Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12)</article-title>. <source>Neurology</source>. <year>2003</year>;<volume>60</volume>:<fpage>31</fpage>-<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr15-1545968312437943">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Motl</surname><given-names>RW</given-names></name>
<name><surname>Snook</surname><given-names>EM</given-names></name>
<name><surname>Agiovlasitis</surname><given-names>S</given-names></name>
</person-group>. <article-title>Calibration of accelerometer output for ambulatory adults with multiple sclerosis</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2009</year>;<volume>90</volume>:<fpage>1778</fpage>-<lpage>1784</lpage>.</citation>
</ref>
<ref id="bibr16-1545968312437943">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Conklyn</surname><given-names>D</given-names></name>
<name><surname>Stough</surname><given-names>D</given-names></name>
<name><surname>Novak</surname><given-names>E</given-names></name>
<name><surname>Paczak</surname><given-names>S</given-names></name>
<name><surname>Chemali</surname><given-names>K</given-names></name>
<name><surname>Bethoux</surname><given-names>F</given-names></name>
</person-group>. <article-title>A home-based walking program using rhythmic auditory stimulation improves gait performance in patients with multiple sclerosis: a pilot study</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2010</year>;<volume>24</volume>:<fpage>835</fpage>-<lpage>842</lpage>.</citation>
</ref>
<ref id="bibr17-1545968312437943">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ratchford</surname><given-names>JN</given-names></name>
<name><surname>Shore</surname><given-names>W</given-names></name>
<name><surname>Hammond</surname><given-names>ER</given-names></name>
<etal/>
</person-group>. <article-title>A pilot study of functional electrical stimulation cycling in progressive multiple sclerosis</article-title>. <source>NeuroRehabilitation</source>. <year>2010</year>;<volume>27</volume>:<fpage>121</fpage>-<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr18-1545968312437943">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abellan Van Kan</surname><given-names>G</given-names></name>
<name><surname>Rolland</surname><given-names>Y</given-names></name>
<name><surname>Andrieu</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Gait speed at usual pace is a predictor of adverse outcomes in community-dwelling older people: an International Academy on Nutrition and Aging (IANA) Task Force</article-title>. <source>J Nutr Health Aging</source>. <year>2009</year>;<volume>13</volume>:<fpage>881</fpage>-<lpage>889</lpage>.</citation>
</ref>
<ref id="bibr19-1545968312437943">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Perera</surname><given-names>S</given-names></name>
<name><surname>Moody</surname><given-names>SH</given-names></name>
<name><surname>Woodman</surname><given-names>RC</given-names></name>
<name><surname>Studenski</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Meaningful change and responsiveness in common physical performance measures in older adults</article-title>. <source>J Am Geriatr Soc</source>. <year>2006</year>;<volume>54</volume>:<fpage>743</fpage>-<lpage>749</lpage>.</citation>
</ref>
<ref id="bibr20-1545968312437943">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ralston</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Energy-speed relation and optimal speed during level walking</article-title>. <source>Int Z Angew Physiol</source>. <year>1958</year>;<volume>17</volume>:<fpage>277</fpage>-<lpage>283</lpage>.</citation>
</ref>
<ref id="bibr21-1545968312437943">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gijbels</surname><given-names>D</given-names></name>
<name><surname>Alders</surname><given-names>G</given-names></name>
<name><surname>Van Hoof</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures</article-title>. <source>Mult Scler</source>. <year>2010</year>;<volume>16</volume>:<fpage>618</fpage>-<lpage>626</lpage>.</citation>
</ref>
<ref id="bibr22-1545968312437943">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kos</surname><given-names>D</given-names></name>
<name><surname>Kerckhofs</surname><given-names>E</given-names></name>
<name><surname>Nagels</surname><given-names>G</given-names></name>
<name><surname>D’hooghe</surname><given-names>MB</given-names></name>
<name><surname>Illsbroukx</surname><given-names>S</given-names></name>
</person-group>. <article-title>Origin of fatigue in multiple sclerosis: review</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2008</year>;<volume>22</volume>:<fpage>91</fpage>-<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr23-1545968312437943">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steens</surname><given-names>A</given-names></name>
<name><surname>de Vries</surname><given-names>A</given-names></name>
<name><surname>Hemmen</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Fatigue perceived by multiple sclerosis patients is associated with muscle fatigue</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2012</year>;<volume>26</volume>:<fpage>48</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr24-1545968312437943">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iyengar</surname><given-names>V</given-names></name>
<name><surname>Santos</surname><given-names>MJ</given-names></name>
<name><surname>Ko</surname><given-names>M</given-names></name>
<name><surname>Aruin</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Grip force control in individuals with multiple sclerosis</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2009</year>;<volume>23</volume>:<fpage>855</fpage>-<lpage>861</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>